Oct 15 (Reuters) - Abbott (ABT.N), opens new tab missed analysts' third-quarter revenue estimates on Wednesday, as weakness in its diagnostics and nutrition businesses outweighed robust demand for its ...
Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...
ACTON, Mass. and YAMANASHI, Japan, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics company focused on developing rapid near-patient ...
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care ...
Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...
Oct 7 (Reuters) - BillionToOne filed for an initial public offering in the United States on Tuesday. The company's filing comes at a time when U.S. IPO activity is picking up, reversing a slowdown ...
The VasCog-2-WSO criteria update the 2014 VasCog guidelines for diagnosing vascular cognitive impairment and dementia, incorporating biomarkers, imaging features, and standardized cognitive domains to ...
Not being able to turn off Send optional diagnostic data settings undermines our privacy and control and can be really frustrating. This issue often occurs when system policies, background services, ...
Mirvie is a biotechnology company in San Francisco, California, that is developing blood tests that can predict pregnancy complications. It hopes its RNA-based technology will offer a non-invasive way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback